SE8002222L - Oxytocin-derivat - Google Patents

Oxytocin-derivat

Info

Publication number
SE8002222L
SE8002222L SE8002222A SE8002222A SE8002222L SE 8002222 L SE8002222 L SE 8002222L SE 8002222 A SE8002222 A SE 8002222A SE 8002222 A SE8002222 A SE 8002222A SE 8002222 L SE8002222 L SE 8002222L
Authority
SE
Sweden
Prior art keywords
derivatives
oxytocin
inhibitory effect
new
uterine contractions
Prior art date
Application number
SE8002222A
Other languages
English (en)
Other versions
SE430885B (sv
Inventor
P O R Melin
Original Assignee
Ferring Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Ab filed Critical Ferring Ab
Priority to SE8002222A priority Critical patent/SE430885B/sv
Priority to US06/238,715 priority patent/US4402942A/en
Priority to CH140781A priority patent/CH646139A5/de
Priority to GB8106843A priority patent/GB2074582B/en
Priority to DE3108323A priority patent/DE3108323C2/de
Priority to NL8101191A priority patent/NL8101191A/nl
Priority to BE0/204141A priority patent/BE887970A/fr
Priority to FR8105751A priority patent/FR2482093A1/fr
Priority to JP4227581A priority patent/JPS56150050A/ja
Priority to IT20684/81A priority patent/IT1136574B/it
Publication of SE8002222L publication Critical patent/SE8002222L/sv
Publication of SE430885B publication Critical patent/SE430885B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/16—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8002222A 1980-03-24 1980-03-24 Oxytocin-derivat SE430885B (sv)

Priority Applications (10)

Application Number Priority Date Filing Date Title
SE8002222A SE430885B (sv) 1980-03-24 1980-03-24 Oxytocin-derivat
US06/238,715 US4402942A (en) 1980-03-24 1981-02-27 Oxytocin derivatives
CH140781A CH646139A5 (de) 1980-03-24 1981-03-03 Oxytocin-derivate.
GB8106843A GB2074582B (en) 1980-03-24 1981-03-04 Oxytocin-derivatives
DE3108323A DE3108323C2 (de) 1980-03-24 1981-03-05 1-Desamino (2-O-alkyltyrosin)-oxytocine und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
NL8101191A NL8101191A (nl) 1980-03-24 1981-03-11 Oxytocine derivaat; farmaceutisch preparaat; werkwijze voor het tegengaan van spiercontracties van de uterus.
BE0/204141A BE887970A (fr) 1980-03-24 1981-03-16 Nouveaux derives d'ocytocine et compositions pharmaceutiques contenant ces derives
FR8105751A FR2482093A1 (fr) 1980-03-24 1981-03-23 Nouveaux derives d'ocytocine et compositions pharmaceutiques contenant ces derives
JP4227581A JPS56150050A (en) 1980-03-24 1981-03-23 Oxitocin derivative
IT20684/81A IT1136574B (it) 1980-03-24 1981-03-24 Derivati della ossitocina

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8002222A SE430885B (sv) 1980-03-24 1980-03-24 Oxytocin-derivat

Publications (2)

Publication Number Publication Date
SE8002222L true SE8002222L (sv) 1981-09-25
SE430885B SE430885B (sv) 1983-12-19

Family

ID=20340577

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8002222A SE430885B (sv) 1980-03-24 1980-03-24 Oxytocin-derivat

Country Status (10)

Country Link
US (1) US4402942A (sv)
JP (1) JPS56150050A (sv)
BE (1) BE887970A (sv)
CH (1) CH646139A5 (sv)
DE (1) DE3108323C2 (sv)
FR (1) FR2482093A1 (sv)
GB (1) GB2074582B (sv)
IT (1) IT1136574B (sv)
NL (1) NL8101191A (sv)
SE (1) SE430885B (sv)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3363830D1 (en) * 1982-12-21 1986-07-03 Ferring Ab Vasotocin derivatives
SE8207277L (sv) * 1982-12-21 1984-06-22 Ferring Ab Vasotocin-derivat
US4483794A (en) * 1983-05-10 1984-11-20 Ceskoslovenska Akademie Ved Analogs of neurohypophysial hormones
US4624943A (en) * 1985-03-20 1986-11-25 Smithkline Beckman Corporation Aromatic basic-tailed vasopressin antagonists
US5225528A (en) * 1990-02-27 1993-07-06 Merck & Co., Inc. Cyclic hexapeptide oxytocin antagonists
DE4042008A1 (de) * 1990-12-22 1992-06-25 Schering Ag Vasopressin-derivate
US5830848A (en) * 1992-10-09 1998-11-03 The Regents Of The University Of California Method and agents for inducement of endogenous nitric oxide synthase for control and management of labor during pregnancy
US6909024B1 (en) 1999-11-22 2005-06-21 The Dow Chemical Company Process for the conversion of ethylene to vinyl chloride and novel catalyst compositions useful for such process
US6680415B1 (en) 1999-11-22 2004-01-20 Dow Global Technologies Inc. Oxyhalogenation process using catalyst having porous rare earth halide support
US6933417B1 (en) 1999-11-22 2005-08-23 Dow Global Technologies Inc. Process for vinyl chloride manufacture from ethane and ethylene with partial CHl recovery from reactor effluent
US6797845B1 (en) 1999-11-22 2004-09-28 Dow Global Technologies Inc. Process for vinyl chloride manufacture from ethane and ethylene with immediate HCl recovery from reactor effluent
SE0100684D0 (sv) * 2001-02-28 2001-02-28 Kerstin Uvnaes Moberg New subject-matter
KR100886284B1 (ko) * 2001-05-23 2009-03-04 다우 글로벌 테크놀로지스 인크. Ｃ3＋ 탄화수소의 산화성 할로겐화 및 임의의 탈수소화
US20040152929A1 (en) * 2002-05-08 2004-08-05 Clarke William D Process for vinyl chloride manufacture from ethane and ethylene with air feed and alternative hcl processing methods
US7722733B2 (en) 2004-03-29 2010-05-25 Baxter International Inc. Method for sterile connection of tubing
TWI463990B (zh) * 2009-09-21 2014-12-11 Ferring Bv 催產素受體促進劑
EP3212212B1 (en) 2014-10-31 2020-09-23 Monash University Powder formulation
JP6933322B2 (ja) 2016-01-04 2021-09-08 メルク セローノ エス．エー． ヒドロキシプロピルチアゾリジンカルボキサミド誘導体のｌ−バリネート及びその塩形態、結晶多形
CA3031252A1 (en) 2016-07-21 2018-01-25 ObsEva S.A. Oxytocin antagonist dosing regimens for promoting embryo implantation and preventing miscarriage
JP7390031B2 (ja) * 2018-12-27 2023-12-01 国立大学法人金沢大学 オキシトシン誘導体及びその使用
WO2021043726A1 (en) 2019-09-03 2021-03-11 ObsEva S.A. Oxytocin antagonist dosing regimens for promoting embryo implantation and preventing miscarriage
US20230102503A1 (en) 2020-02-10 2023-03-30 ObsEva S.A. Biomarkers for oxytocin receptor antagonist therapy
CN116723838A (zh) 2020-11-16 2023-09-08 艾克索玛(美国)有限责任公司 用于治疗或预防早产的组合物和方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1463865A (fr) * 1964-07-27 1966-07-22 Ceskoslovenska Akademie Ved Procédé pour la préparation des dérivés cycliques de peptides ainsi que les produits conformes à ceux obtenus par le présent procédé ou procédé similaire
CS194980B1 (en) * 1976-07-16 1979-12-31 Joseph H Cort Agent for current induction,fertilization facilitating and milkability increasing at mammals,especially at utility cattle

Also Published As

Publication number Publication date
DE3108323A1 (de) 1981-12-24
SE430885B (sv) 1983-12-19
FR2482093A1 (fr) 1981-11-13
IT8120684A0 (it) 1981-03-24
GB2074582A (en) 1981-11-04
BE887970A (fr) 1981-07-16
GB2074582B (en) 1983-07-06
US4402942A (en) 1983-09-06
IT1136574B (it) 1986-09-03
CH646139A5 (de) 1984-11-15
JPS56150050A (en) 1981-11-20
FR2482093B1 (sv) 1984-11-09
DE3108323C2 (de) 1983-11-24
NL8101191A (nl) 1981-10-16

Similar Documents

Publication Publication Date Title
SE8002222L (sv) Oxytocin-derivat
ES429710A1 (es) Un procedimiento para la preparacion de nuevos n,n'-bis- (beta-hidroxi-ariletil)-diaminoalcanos.
TW249804B (sv)
JPS5419990A (en) Dihydrotriazinylthioxacephalosporin
JPS5430184A (en) 3,4-dihydrocarbostyril derivative
ES471672A1 (es) Un procedimiento para la preparacion de un peptido
IL83967A (en) Pharmaceutical compositions comprising antigestagens for the inhibition of uterine synthesis of prostaglandin
JPS5419969A (en) Proline derivative and its preparation
JPS5225740A (en) Preparation of o-acyl-amidinophenols or acid addition salts thereof
JPS52100470A (en) Synthesis of hydantoin derivatives
ES8307258A1 (es) "procedimiento para la preparacion de nuevas cefalosporinas".
ES474985A1 (es) Procedimiento para la preparacion de derivados de la isoqui-noleina
ES479033A1 (es) Un procedimiento para la preparacion de derivados de n-iminometil piperidina.
GB1000783A (en) Improvements in or relating to pharmaceutical compositions containing polyhydroxybenzene derivatives
ES441244A1 (es) Metodo de preparar compuestos esteres basicos.
JPS5273878A (en) Synthesis of 6-carboxyacetyl-3,4-dihydrocarbostyril
JPS5427578A (en) 1-carboxyalkylcarbamoyl-5-fluorouracil derivatives and their preparation
JPS51138660A (en) Process for prep aration of polycyclic urethanes
GB931019A (en) Pharmaceutical compositions containing quinazolone compounds
JPS51133487A (en) Process for preparing 3-amino-1-(alpha -carboxy-4-hydroxybenzyl)-2-azetidi nones
JPS5223049A (en) Preparation of 4-acloxy-4'- cyanobiphenyls
JPS5430167A (en) 4-aminomethyl-2-phenyloxazoles and their pharmaceutically acceptable acid salts
JPS5265255A (en) Synthesis of tetrahydronaphthylamine derivatives
JPS52270A (en) Hydantoin germicides for agriculture and gardening
JPS5219669A (en) Preparation of tetrazole derivatives and acid addition salts thereof

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8002222-1

Effective date: 19890426

Format of ref document f/p: F